Bleakley Financial Group, LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1936953
PARSIPPANY, NJ
Position in TMO
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$11,241,995
+$2,421,981 QoQ
Shares Held
22,423
+25.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#621
of 2,606 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Bleakley Financial Group, LLC holds $17,740,761 across 3 Diagnostics & Research names. TMO ranks #1 (63.4% of the industry book) .
All Filings in TMO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,241,995 | 22,423 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $8,820,014 | 17,944 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $10,602,776 | 18,298 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $7,481,433 | 15,425 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $5,646,030 | 13,925 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $7,197,784 | 14,465 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $6,174,089 | 11,868 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $6,838,909 | 11,056 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $13,644,169 | 24,673 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $14,435,512 | 24,837 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $16,304,276 | 30,717 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $16,036,477 | 31,682 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,592,825 | 27,969 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,748,159 | 29,058 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,606,554 | 28,340 | Shares | Sole | 2023-02-07 | |
| No filing history on record for this holder in this stock. | ||||||